Silo Pharma Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Silo Pharma.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Silo Pharma.

Recommendation Trends

Rating	Aug '23
Strong Buy	0
Buy	0
Hold	0
Sell	0
Strong Sell	0
Total	0

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yale Jen Laidlaw & Co.	Laidlaw & Co.	Strong Buy Initiates $10	Strong Buy	Initiates	$10	+834.58%	Aug 28, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

73.44K

from 72.10K

1.86%

from 72.10K

Revenue Next Year

73.44K

from 73.44K

EPS This Year

-0.71

from -1.19

EPS Next Year

-0.73

from -0.71

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	71.26K	72.10K	72.10K	72.10K	73.44K	73.44K
Revenue Growth	-	-	1.18%	-	-	1.86%	-
EPS	-2.78	1.30	-1.71	-1.20	-1.19	-0.71	-0.73
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	75,600	75,600
Avg	73,440	73,440
Low	70,560	70,560

Revenue Growth

Revenue Growth	2025	2026
High	4.9%	2.9%
Avg	1.9%	-
Low	-2.1%	-3.9%

EPS Forecast

EPS	2025	2026
High	-0.74	-0.76
Avg	-0.71	-0.73
Low	-0.69	-0.71

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.